Viatris says reached 'agreement' to resolve UK litigation risk over perindopril
MLex Summary: Viatris has "reached an agreement in principle to resolve" its involvement in UK antitrust litigation from health authorities over the supply of blood pressure drug perindopril, the company said...To view the full article, register now.
Already a subscriber? Click here to view full article